LINC01568: A Potential Drug Target and Biomarker (G100506172)

Target Name: LINC01568

NCBI ID: G100506172

LINC01568

Other Name(s): long intergenic non-protein coding RNA 1568 | Long intergenic non-protein coding RNA 1568

LINC01568: A Potential Drug Target and Biomarker

LINC01568 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell adhesion and has been shown to play a role in various diseases, including cancer. LINC01568 is a strong candidate for drug targeting due to its unique structure, its expression pattern in different tissues, and its involvement in cellular signaling pathways.

Structure and Expression

LINC01568 is a non-coding RNA molecule that consists of 22 amino acid residues. It has a unique structure, with a three-dimensional structure that is reminiscent of a hinge. The molecule has a single open reading frame and a single exon. It is expressed in various tissues, including brain, heart, and liver. The expression pattern of LINC01568 varies between tissues, with higher levels of expression in brain and placenta.

Function

LINC01568 is involved in cell adhesion and has been shown to play a role in various diseases, including cancer. It is a key regulator of cell-cell adhesion and has been shown to promote the formation of tight junctions, which are essential for maintaining tissue structure and function. LINC01568 has also been shown to play a role in the regulation of cell proliferation and has been linked to the development of cancer.

Drug Targeting

LINC01568 is a strong candidate for drug targeting due to its unique structure and its involvement in cellular signaling pathways. Drugs that target LINC01568 have the potential to treat various diseases, including cancer, neurodegenerative diseases, and developmental disorders. One of the promising drugs that targets LINC01568 is a small molecule inhibitor, which has been shown to inhibit the activity of LINC01568 and prevent the formation of tight junctions.

Biomarker

LINC01568 has also been identified as a potential biomarker for various diseases, including cancer. Its expression pattern varies between tissues, making it an attractive biomarker for cancer diagnosis and treatment. LINC01568 has been shown to be downregulated in various types of cancer, including breast, lung, and colon cancer. This suggests that LINC01568 may be a useful biomarker for cancer detection and treatment.

Conclusion

In conclusion, LINC01568 is a non-coding RNA molecule that has a unique structure and is involved in various diseases, including cancer. Its expression pattern varies between tissues and its involvement in cellular signaling pathways make it a promising candidate for drug targeting. Additionally, LINC01568 has also been identified as a potential biomarker for cancer detection and treatment. Further research is needed to fully understand the role of LINC01568 in diseases and to develop effective drugs that target it.

Protein Name: Long Intergenic Non-protein Coding RNA 1568

The "LINC01568 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01568 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets